SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-21-023843
Filing Date
2021-02-16
Accepted
2021-02-16 16:01:08
Documents
2
Group Members
DALIA BLEYERIAN CHAROUBNEXTECH VI GP S.A R.L.ROCCO SGOBBO

Document Format Files

Seq Description Document Type Size
1 SC 13G tm216872d4_sc13g.htm SC 13G 104721
2 EXHIBIT 99.1 tm216872d4_ex99-1.htm EX-99.1 7880
  Complete submission text file 0001104659-21-023843.txt   114196
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Subject) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91894 | Film No.: 21637727
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8, RUE LOU HEMMER SENNINGERBERG N4 L-1748
Business Address 8, RUE LOU HEMMER SENNINGERBERG N4 L-1748 41 44 366 66 10
NEXTECH VI ONCOLOGY SCSP (Filed by) CIK: 0001804218 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G